Live Breaking News & Updates on Robert Flisiak

Stay updated with breaking news from Robert flisiak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hepatitis C Genotype, Cirrhosis, Gender May Impact Effectiveness of DAA Therapy

Although the overall response rate among the cohort was 96.4%, this figure dropped as low as 66.7% when accounting for male gender, GT3 infection, cirrhosis, obesity, and non-response to previous therapy. ....

Sofosbuvir Velpatasvir , Robert Flisiak , University Of Bialystok , University Of Bialystok Robert Flisiak , World Health Organization , Medical University , March Intern , Hepatitis C , Direct Acting Antiviral , Sustained Virological Response ,

The Warsaw Voice

Coronavirus returns, COVID-19 drug still without r ....

Grazyna Cholewinska , Franciszek Rakowski , Robert Flisiak , Dziennik Gazeta Prawna , European Medicines Agency , Society Of Epidemiologists , Ministry Of Health , Warsaw University Interdisciplinary Center , Material Reserve Agency , Health Ministry , National Health Fund , Polish Society , Infectious Diseases , Warsaw University , Interdisciplinary Center , Computer Modeling ,

Legionnaires' Disease Outbreak in Poland Kills 16

Infections have surged in Rzeszow, whose strategic location near the Ukrainian border has transformed it into a hub for the Western response to Russia’s invasion. ....

United States , Stanislaw Zaryn , Robert Flisiak , Association Of Epidemiologists , Us Centers For Disease , Polish Association , Disease Control , Professor Flisiak , Legionnaires Disease ,

Can Paxlovid, Molnupiravir Benefit Hospitalized COVID Patients Too?

Antivirals were associated with lower all-cause mortality and illness severity during BA.2 ....

Hong Kong , University Of Hong Kong , Hong Kong General , Ingrid Hein , Dorota Zar , Robert Flisiak , Carlos Wong , University Of Bia , Jan Kochanowski University In Kielce , Lancet Infectious , Jan Kochanowski University , Medical University , Medpage Today , Infect Dis ,

Paxlovid, molnupiravir benefit older COVID-19 patients, 2 studies show

The drugs reduced disease progression, hospitalization, and death in seniors. ....

Hong Kong , United States , University Of Hong Kong , Hong Kong General , Tel Aviv , Dorota Zarebska Michaluk , Robert Flisiak , Clalit Health Services , Jan Kochanowski University , Drug Administration , University Of Bialystok , New England Journal , Lancet Infectious , Medical University ,